Investing.com - Financial Markets Worldwide

DaVita HealthCare Partners Inc (DVA)

NYSE
Symbol
Exchange
Currency
DVANYSEUSD
DVATradeGateEUR
Currency in USD
158.65
+1.59(+1.01%)
Real-time Data
DVA Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Unlock Value
Day's Range
156.92160.17
52 wk Range
103.40169.52
Key Statistics
Edit
Prev. Close
157.06
Open
157.36
Day's Range
156.92-160.17
52 wk Range
103.4-169.52
Volume
217.74K
Average Volume (3m)
766.95K
1-Year Change
43.96%
Book Value / Share
4.61
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DVA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Technical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
156.93
Downside
-1.09%
Members' Sentiments
Bearish
Bullish
ProTips
pro lock
Unlock All 11
3 analysts have revised their earnings upwards for the upcoming period
Unlock InvestingPro

DaVita HealthCare Partners Inc News & Analysis

Show more

DaVita HealthCare Partners Inc Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Industry
Healthcare Providers & Services
Sector
Healthcare
Employees
70000
Market
United States

DaVita HealthCare Partners Inc SWOT Analysis

Dialysis Dominance
Explore DaVita's market leadership in kidney care services, with $12.67 billion in annual revenue and a vast network of dialysis centers across the United States
Regulatory Resilience
Learn how DaVita navigates complex healthcare policies, including the impact of CMS proposals on ESRD rates and the inclusion of phosphate binders in payment bundles
Financial Fortitude
Delve into DaVita's robust financial management, absorbing supply chain challenges while maintaining EBIT guidance and projecting 3-7% operating income growth for 2025
Market Valuation
Analysts set price targets ranging from $150 to $164, with DaVita trading above its Fair Value, highlighting the need for careful investor consideration
Read full SWOT analysis

DaVita HealthCare Partners Inc Earnings Call Summary for Q3/2024

  • DaVita maintains 2024 guidance: $1.91-$2.01B adjusted operating income, $9.25-$10.05 EPS, despite hurricane impacts
  • Q3 results: $535M adjusted operating income, $2.59 EPS; flat treatment volume growth, increased revenue per treatment
  • Debt management successful: nearest maturity in 2028, leverage within target; 2.7M shares repurchased in Q3
  • Anticipates 50-100 bps treatment growth for full year; preparing for operational adjustments and growth opportunities
  • Expects CMS 2025 rule to include oral-only drugs in Medicare Part B; international growth potential highlighted
Last Updated: 10/31/2024, 02:14 AM
Read Full Transcript

Compare DVA to Peers and Sector

Metrics to compare
DVA
Peers
Sector
Relationship
P/E Ratio
15.8x−1.7x−0.6x
PEG Ratio
0.37−0.100.00
Price/Book
33.9x1.6x2.6x
Price / LTM Sales
1.0x1.0x3.1x
Upside (Analyst Target)
4.7%54.8%55.4%
Fair Value Upside
Unlock31.0%10.2%Unlock

Analyst Ratings

1 Buy
6 Hold
2 Sell
Ratings:
9 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 156.93

(-1.09% Downside)

Earnings

Latest Release
Oct 29, 2024
EPS / Forecast
2.59 / 2.72
Revenue / Forecast
3.26B / 3.25B
EPS Revisions
a
a
Unlock
Last 90 days

People Also Watch

VeriSign
210.55
VRSN
+0.47%
Moody’s
460.68
MCO
+0.61%
Kroger
60.06
KR
+0.96%
Visa A
308.48
V
+0.51%
Aon
359.52
AON
+1.36%

FAQ

What Is the DaVita (DVA) Stock Price Today?

The DaVita stock price today is 158.65

What Stock Exchange Does DaVita Trade On?

DaVita is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for DaVita?

The stock symbol for DaVita is "DVA."

What Is the DaVita Market Cap?

As of today, DaVita market cap is 13.03B.

What is DaVita Earnings Per Share?

The DaVita EPS is 9.49.

What Is the Next DaVita Earnings Date?

DaVita will release its next earnings report on Feb 17, 2025.

From a Technical Analysis Perspective, Is DVA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.